Molbio Diagnostics Ltd

₹1,574.4
+10.15% today
₹18,143 Cr · Mid cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dHealth Care Equipment & Supplies 20.0%-20.0 pts

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is MOLBIO early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
—
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 8
1w13w26w
Week 8 — early Stage 2, building
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
—
—
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
—
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↑
MA20 trending up · +8.4% vs MA50 —
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+20.5%
3M
—
6M
—
YTD
—
1Y
—
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Health Care Equipment & Supplies
↓ Peaking
Stage 2%
20.0%
20d Δ
-20.0pp
1M return
+2.8%
3M return
-8.0%
Industry Stage-2 % · last 20 days
Industry has 2 Stage 2 leaders. See Health Care Equipment & Supplies Stage 2 →
Stage Cycle Timeline2026-08-24 → 2026-10-16
S? 8w
2026-08-242026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 8w current
Total tracked: 8 weeks across 1 stage run.
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-16S—
Wk 8 · Vol —x
2026-10-15S—
Wk 8 · Vol —x
2026-10-14S—
Wk 8 · Vol —x
2026-10-13S—
Wk 7 · Vol —x
2026-10-12S—
Wk 7 · Vol —x
2026-10-09S—
Wk 7 · Vol —x
2026-10-08S—
Wk 7 · Vol —x
2026-10-07S—
Wk 7 · Vol —x
2026-10-06S—
Wk 6 · Vol —x
2026-10-05S—
Wk 6 · Vol —x
2026-10-01S—
Wk 6 · Vol —x
2026-09-30S—
Wk 6 · Vol —x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
—
200 DMA
—
52W High
—
52W Low
—
5D Low
₹1,429.3
Resistance levels (recent highs)
20d High
₹1,574.4
60d High
—
120d High
—
250d High
—
Next resistance
Above all
Ask the Market AI about MOLBIOAsk →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.